Education & Training
Medical School
University of Missouri School of Medicine
Internship
Internal Medicine
- University of Missouri Hospitals And Clinics
Residency
Dermatology
- University of Missouri Hospitals And Clinics
Fellowship
Pediatric Dermatology
- Children's Memorial Hospital
Boards
Insurances
MU Health Care participates with most major managed care organizations. To find out whether MU Health Care is a participating provider in your insurance plan or network, or for information on co-payments and deductibles, please contact your insurance carrier directly.
In the News
Academic Information
Research Profile
As a pediatric dermatologist, Dr. Dyer is interested in cutaneous biology and disease especially as it applies to infants and children. He has several areas of interest that include genetic and epigenetic skin disease, transcutaneous exposure to environmental endocrine disruptors and epigenetic impacts, pediatric teledermatology, loxoscelism, the long-term impacts of systemic therapy for pediatric vascular lesions, the impacts of pediatric skin disorders on sleep in patients and families through the use of wearables and/or biomarkers, and spitz nevi and pediatric pigmented lesions.
Dr. Dyer is helping to launch a pediatric dermatology clinic to enhance pediatrician and primary care dermatologic knowledge in rural areas through the Extension for Community Healthcare Outcomes (ECHO) project. He is also involved in dermatologic clinic trials and has brought pediatric clinical trials to MU Health Care.
Research Interests
- Pediatric Dermatology
- Genodermatoses
- Cutaneous Mosaicism
- Epigenetics
- Transcutaneous exposure to environmental endocrine disruptors
- Loxoscelism and Necrotic Arachnidism
- Pediatric Teledermatology
- Birthmarks (vascular; pigmented; other)
- Severe atopic dermatitis
- Cutaneous Infectious Disease
- Viral infections
- Pediatric Psoriasis
Areas of Expertise
- Pediatric Dermatology
- Genodermatoses
- Cutaneous Mosaicism
- Pediatric teledermatology
- Birthmarks (vascular and pigmented)
- Severe atopic dermatitis
- Cutaneous and systemic arachnidism
- Transcutaneous exposure to endocrine disruptors